Monrovia, CA -- (SBWire) -- 02/27/2012 --Brock Reeve, Executive Director, Stem Cell & Cancer Research Institute, Harvard Stem Cell Institute to give a Featured Presentation on “The Latest From The Lab” at the 8th Stem Cell Summit (April 19-20, 2012 in Boston, MA)

The Latest From The Lab

In the current environment, the commercial sector is increasingly dependent on interactions with academia for new ideas and the latest science, especially in a field where the knowledge base is literally growing at an exponential rate. This talk will highlight some of the more recent findings in the field of stem cell science that are coming out of the leading labs of the Harvard Stem Cell Institute. Examples of stem cells in their uses as tools, as targets and as therapies will be discussed as well as examples of what we have learned as a result of knowing more about biology and disease. The implications of these findings for the clinic and the market will be highlighted.

The 8th Stem Cell Summit includes two concurrent tracks including a couple joint sessions. This summit provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and the business of Stem Cells.

Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, stem cell reprogramming, and regulatory policies regarding stem cell research will be addressed.

In addition, focuses on the business opportunities, challenges and potential strategies for overcoming these challenges will be addressed. What categories of companies are currently commercially viable? How are they being funded? What kind of strategic relationships are available within the industry?

Session Topics for each track are shown below:

Track 1: Stem Cell Research & Regenerative Medicine:
-Funding Opportunities (Joint Session)
-Regulatory Guidance & Updates (Joint Session)
-Novel Advances in Stem Cell Research
-Advances in Regenerative Medicine and Tissue Engineering
-Overcoming Challenges in Clinical Development
-Bringing Research to Drug Discovery

Track 2: Stem Cell Commercialization & Partnering:
-Funding Opportunities (Joint Session)
-Regulatory Guidance & Updates (Joint Session)
-Novel Technologies in Stem Cell Research
-Partnerships & Acquisitions
-Panel Discussion: Partnerships & Acquisitions
-Commercialization: Bringing Drug to Market
-Panel Discussion: Commercialization: Bringing Drug to Market

Keynote & Featured Speakers Include:
Glen Prestwich, Presidential Professor, Department of Medicinal Chemistry, University of Utah
Douglas Losordo, Vice President, Medical Director, New Therapies, Baxter
Leanna Caron, Vice President, Cell Therapy & Regenerative Medicine, Genzyme
Devyn Smith, Chief Operating Officer, Neusentis Research Unit, Pfizer
Sridaran Natesan, Scientific Site Head & Head, External Innovation & Partnering, Sanofi-Aventis
Brock Reeve, Executive Director, Stem Cell & Cancer Research Institute, Harvard Stem Cell Institute
Tiina Palomäki, SWP and CPWP, EMA, & Finnish Medicines Agency
Gregory Bonfiglio, Managing Partner, Proteus Venture Partners

The Stem Cell Summit will also be running concurrently with GTC’s 2nd Diabetes Summit.

For more information, please visit http://www.gtcbio.com